Dexcom Inc. buy Wells Fargo & Company
Start price
13.12.23
/
50%
€111.70
Target price
13.12.24
€126.03
Performance (%)
-44.46%
Price
04.10.24
€62.04
Summary
This prediction is currently active. Massive losses of -44.46% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 13.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dexcom Inc. | 2.954% | 2.954% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Wells Fargo & Company from $110.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for DXCM provided by MarketBeat